
doi: 10.1056/nejmc1009101
N Engl J Med
Immunosuppressive Agents/*adverse effects/therapeutic use, Patient Selection, Remission Induction, therapy/mortality, Cyclophosphamide/adverse effects/*therapeutic use, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antibodies, Monoclonal, Murine-Derived/*adverse effects/therapeutic use, Neoplasms/*chemically induced, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/*drug, Kidney Diseases/*drug therapy/mortality, Antibodies, Monoclonal, Murine-Derived, Neoplasms, Humans, Kidney Diseases, Treatment Failure, Rituximab, Cyclophosphamide, Immunosuppressive Agents
Immunosuppressive Agents/*adverse effects/therapeutic use, Patient Selection, Remission Induction, therapy/mortality, Cyclophosphamide/adverse effects/*therapeutic use, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antibodies, Monoclonal, Murine-Derived/*adverse effects/therapeutic use, Neoplasms/*chemically induced, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/*drug, Kidney Diseases/*drug therapy/mortality, Antibodies, Monoclonal, Murine-Derived, Neoplasms, Humans, Kidney Diseases, Treatment Failure, Rituximab, Cyclophosphamide, Immunosuppressive Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1K | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 0.1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 0.1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.01% |
